Epidemiological Markers for Interactions among Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Upper Respiratory Tract Carriage

Journal of Infectious Diseases

Volumn 213, Issue 10, 2016, Pages 1596-1605

  Lewnard, Joseph A ^a   Givon Lavi, Noga ^b,c   Huppert, Amit ^d   Pettigrew, Melinda M ^a   Regev Yochay, Gili ^e,f   Dagan, Ron ^b,c   Weinberger, Daniel M ^a  

^a YALE UNIVERSITY   (United States)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d Section of Biostatistics   (United States)

^e GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^f SHEBA MEDICAL CENTER   (Israel)

Author keywords

Haemophilus influenzae; Pneumococcal conjugate vaccine; Serotype replacement; Staphylococcus aureus; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE; VACCINE;

AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CARRIER; BEDOUIN; CHILD; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; ISRAEL; JEW; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEASONAL VARIATION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; UPPER RESPIRATORY TRACT; CONTROLLED STUDY; HAEMOPHILUS INFECTIONS; HETEROZYGOTE; IMMUNOLOGY; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; MICROBIOLOGY; PNEUMOCOCCAL INFECTIONS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTIONS; RISK FACTOR; STAPHYLOCOCCAL INFECTIONS;

CARRIER STATE; CHILD, PRESCHOOL; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; HUMANS; INFANT; ISRAEL; LONGITUDINAL STUDIES; MALE; PNEUMOCOCCAL INFECTIONS; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 84969931501     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv761     Document Type: Article

References (50)

1. Shak JR, Vidal JE, Klugman KP. Influence of bacterial interactions on pneumococcal colonization of the nasopharynx. Trends Microbiol 2013; 21:129-35.
2. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 2009; 7:887-94.
3. Kopterides P, Falagas ME. Potential consequences of the pneumococcal conjugate vaccine. N Engl J Med 2006; 355:95-6.
4. Regev-Yochay G, Bogaert D, Malley RI, et al. Does pneumococcal conjugate vaccine influence Staphylococcus aureus carriage in children? Clin Infect Dis 2008; 47:289-90.
5. Bogaert D, Van Belkum A, Sluijter M, et al. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 2004; 363:1871-2.
6. Leshem E, Maayan-Metzger A, Rahav G, et al. Transmission of Staphylococcus aureus from mothers to newborns. Pediatr Infect Dis J 2012; 31:360-3.
7. Peacock SJ, Justice A, Griffiths D, et al. Determinants of acquisition and carriage of Staphylococcus aureus in infancy. J Clin Microbiol 2003; 41:5718-25.
8. Lebon A, Labout JAM, Verbrugh HA, et al. Dynamics and determinants of Staphylococcus aureus carriage in infancy: The generation R study. J Clin Microbiol 2008; 46:3517-21.
9. Gray BM, Turner ME, Dillon HC. Epidemiologic studies of Streptococcus pneumoniae in infants. The effects of season and age on pneumococcal acquisition and carriage in the first 24 months of life. Am J Epidemiol 1982; 116:692-703.
10. Stephenson WP, Doern G, Gantz N, Lipworth L, Chapin K. Pharyngeal carriage rates of Haemophilus influenzae, type b and non-b, and prevalence of ampicillinresistant Haemophilus influenzae among healthy day-care children in central Massachusetts. Am J Epidemiol 1985; 122:868-75.
11. Regev-Yochay G, Dagan R, Raz M, et al. Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in Children. JAMA 2004; 292:716-20.
12. Chien Y-W, Vidal JE, Grijalva CG, et al. Density interactions among Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in the nasopharynx of young Peruvian children. Pediatr Infect Dis J 2013; 32:72-7.
13. Madhi SA, Adrian P, Kuwanda L, Cutland C, Albrich WC, Klugman KP. Longterm effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae-and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization-in HIV-Infected and HIVuninfected children. J Infect Dis 2007; 196:1662-6.
14. McNally LM, Jeena PM, Gajee K, et al. Lack of association between the nasopharyngeal carriage of Streptococcus pneumoniae and Staphylococcus aureus in HIV-1-infected South African children. J Infect Dis 2006; 194:385-90.
15. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of communityacquired Staphylococcus aureus infections in children. Clin Infect Dis 2005; 40:1785-91.
16. Leekha S, Diekema DJ, Perencevich EN. Seasonality of staphylococcal infections. Clin Microbiol Infect 2012; 18:927-33.
17. Wertheim HFL, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005; 5:751-62.
18. Watson K, Carville K, Bowman J, et al. Upper respiratory tract bacterial carriage in Aboriginal and non-Aboriginal children in a semi-arid area of Western Australia. Pediatr Infect Dis J 2006; 25:782-90.
19. Israeli Central Bureau of Statistics. Society and population. http://www1.cbs.gov.il. Accessed 2 November 2015.
20. Dagan R, Givon-Lavi N, Greenberg D, Fritzell B, Siegrist CA. Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy. J Infect Dis 2010; 201:1570-9.
21. Dagan R, Givon-Lavi N, Porat N, Greenberg D. The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial. Vaccine 2012; 30:5132-40.
22. Adler A, Givon-Lavi N, Moses AE, Block C, Dagan R. Carriage of community-associated methicillin-resistant Staphylococcus aureus in a cohort of infants in southern Israel: Risk factors and molecular features. J Clin Microbiol 2010; 48:531-8.
23. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 22nd informational supplement. Wayne, PA: National Committee for Clinical Laboratory Standards, 2013.
24. Sherman M, le Cessie S. A comparison between bootstrap methods and generalized estimating equations for correlated outcomes in generalized linear models. Commun Stat Simul Comput 1997; 26:901-25.
25. R Core Team. R: A language and environment for statistical computing. https:// www.r-project.org/. Accessed 1 November 2015.
26. Song JH, Dagan R, Klugman KP, Fritzell B. The relationship between pneumococcal serotypes and antibiotic resistance. Vaccine 2012; 30:2728-37.
27. Dagan R, Barkai G, Givon-Lavi N, et al. Seasonality of antibiotic-resistant Streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy? J Infect Dis 2008; 197:1094-102.
28. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford, United Kingdom: Oxford Univ Press, 1991.
29. Kuehnert MJ, Kruszon-Moran D, HillHA, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 2006; 193:172-9.
30. Patel JA, Alvarez-Fernandez P, Jennings K, Loeffelholz M, McCormick D, Chonmaitree T. Factors affecting Staphylococcus aureus colonization of the nasopharynx in the first 6 months of life. Pediatr Infect Dis J 2015; 34:826-30.
31. Mackenzie GA, Leach AJ, Carapetis JR, Fisher J, Morris PS. Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of pneumococcal disease. BMC Infect Dis 2010; 10:304.
32. Datta F, Erb T, Heininger U, et al. A multicenter, cross-sectional study on the prevalence and risk factors for nasal colonization with Staphylococcus aureus in patients admitted to children's hospitals in Switzerland. Clin Infect Dis 2008; 47:923-6.
33. Reiss-Mandel A, Regev-Yochay G. Staphylococcus aureus and Streptococcus pneumoniae interaction and response to pneumococcal vaccination. Hum Vaccin Immunother 2015; in press.
34. Malley R, Trzcinski K, Srivastava A, Thompson CM, Anderson PW, Lipsitch M. CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci U S A 2005; 102:4848-53.
35. Trzciński K, Thompson CM, Srivastava A, Basset A, Malley R, Lipsitch M. Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells. Infect Immun 2008; 76:2678-84.
36. Lin L, Ibrahim AS, Xu X, et al. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog 2009; 5:e1000703.
37. Margolis E, Yates A, Levin BR. The ecology of nasal colonization of Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus: the role of competition and interactions with host's immune response. BMC Microbiol 2010; 10:59.
38. Weimer KED, Armbruster CE, Juneau RA, Hong W, Pang B, Swords WE. Coinfection with Haemophilus influenzae promotes pneumococcal biofilm formation during experimental otitis media and impedes the progression of pneumococcal disease. J Infect Dis 2010; 202:1068-75.
39. van Gils EJM, Hak E, Veenhoven RH, et al. Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trial. PLoS One 2011; 6:e20229.
40. Spijkerman J, Prevaes SMPJ, van Gils EJM, et al. Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis. PLoS One 2012; 7:e39730.
41. Veenhoven R, Bogaert D, Uiterwaal C, et al. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: A randomised study. Lancet 2003; 361:2189-95.
42. Cohen R, Levy C, Thollot F, et al. Pneumococcal conjugate vaccine does not influence Staphylococcus aureus carriage in young children with acute otitis media. Clin Infect Dis 2007; 45:1583-7.
43. Flasche S, van Hoek AJ, Sheasby E, et al. Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: A crosssectional study. PLoS Med 2011; 8:e1001017.
44. Huang SS, Hinrichsen VL, Stevenson AE, et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 2009; 124: e1-11.
45. Dagan R. Serotype replacement in perspective. Vaccine 2009; 27:c22-4.
46. Regev-Yochay G, Lipsitch M, Basset A, et al. The pneumococcal pilus predicts the absence of Staphylococcus aureus co-colonization in pneumococcal carriers. Clin Infect Dis 2009; 48:760-3.
47. Weinberger DM, Grant LR, Steiner CA, et al. Seasonal drivers of pneumococcal disease incidence: Impact of bacterial carriage and viral activity. Clin Infect Dis 2014; 58:188-94.
48. Walter ND, Taylor TH, Shay DK, et al. Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States. Clin Infect Dis 2010; 50:175-83.
49. Greenberg D, Givon-Lavi N, Broides A, Blancovich I, Peled N, Dagan R. The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers. Clin Infect Dis 2006; 42:897-903.
50. Duffy LC, Faden H, Wasielewski R, Wolf J, Krystofik D. Exclusive breastfeeding protects against bacterial colonization and day care exposure to otitis media. Pediatrics 1997; 100:e7.